A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Oman International Hospital in Muscat, Oman

The Idealmed Global Healthcare Services (Idealmed GHS),  part of the european  health group IGHS, based in Coimbra, Portugal, starts the comissioning of the impressive “Oman International Hospital”.

Having participated in projects in Asia, Europe, Africa and in the Midle East, the extraordinary recently launched “Oman International Hospital” (OIH), is the perfect example of the Idealmed GHS capabilities. The OIH was fully conceived, designed and equipped by Idealmed GHS, that will now operate the Hospital in accordance with the most exigent international standards of quality.

With matchless conditions, the “Oman International Hospital” is already considered a landmark in Oman and assumes the ambition to lead the private health sector in the country and in the region, by providing the most advanced diagnostic and treatment solutions to all its users.

As per vision of the Idealmed GHS, the OIH also hosts a “Med Academy”, fully sustained by Siemens, that will ensure the continous training of all its Human Resources and the implementation of international programmes that promotes the sharing of competences and experiences.

Idealmed GHS integrates the international know-how of the most distinguished organizations, from Universities to R&D Institutions, leading multinacional companies, and other renowned hospital groups worldwide, with the single aim to conceive, develop and operate unique health projects, allowing its partners to have a single entity fully responsible for its implementation and governance.

Idealmed GHS assumes its international linkage with companies like Siemens, IBM, among many others, and the relation with the Academic world, in particular with the University of Coimbra, one of the oldest and most prestigious International Universities, as its key pillars of success.

“Knowing that in a modern world knowledge has no boundaries, at Idealmed GHS we merge the experience of all our partners, crafting healthcare projects and tailoring services to each individual.

“In all our facilities, we integrate culture with science, safety with confort, and aesthetics with functionality. Using the most innovative layouts and engeneering concepts and leading-edge eqquipment solutions, we combine techonlogical sophostication with the know-how of the most skilled and trained Human Resources.

“At Idealmed GHS we assume a disruptive vision for hospitals, leading innovative projects and  maximizing their sustainability and profitability, enhancing the confort and well-being of its users and surpassing their superlative expectations,” stated Dr. José Alexandre Cunha, Chairman Of Idealmed GHS.

“Crafting healthcare projects, tailoring services to each individual.”

“Toghether we do it better.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy